Using Continuous Glucose Monitoring to Support Lifestyle Changes in Adults with Prediabetes A Study of Health Impact, Patient Experience, and Provider Views

What this Trial Is About

Researchers are evaluating the impact of continuous glucose monitoring CGM on adults with prediabetes, a condition where blood sugar levels are higher than normal but not yet high enough to be classified as type 2 diabetes. This study aims to see if wearing a CGM device can help guide behavior changes and health management better than traditional health coaching. It also explores the experiences of both patients and healthcare providers using CGM in prediabetes care. The study involves a randomized controlled trial where participants are assigned to either wear the Abbott Freestyle Libre CGM sensor along with receiving health coaching or to receive health coaching alone. The CGM sensor is worn on the back of the arm for two weeks and linked to a smartphone app for glucose monitoring. The study includes three main visits over about six months, with baseline measurements, follow-up questionnaires, and final assessments. In-depth interviews will be conducted with some participants and healthcare providers to gather feedback on using CGM. Participants will attend three scheduled visits to complete questionnaires about diet and physical activity, have their weight, body mass index, and waist circumference measured, and receive health coaching. Those in the CGM group will be taught how to use the device and app and encouraged to make lifestyle changes based on glucose data. The study will measure changes in diet, physical activity, and body measurements over 24 to 28 weeks while monitoring adherence to the device and gathering qualitative feedback. Healthcare providers will also share their perspectives on CGM integration in prediabetes care.

Continuous Glucose Monitoring (CGM) in Prediabetes